{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:13:02Z","timestamp":1789269182285,"version":"build-2803163510"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Foundation Universidad Alfonso X el Sabio","award":["IX CONVOCATORIA SANTANDER \/ UAX."],"award-info":[{"award-number":["IX CONVOCATORIA SANTANDER \/ UAX."]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196201","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T17:30:29Z","timestamp":1525109429000},"page":"e0196201","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prevalence of and risk factors for low bone mineral density in Spanish treated HIV-infected patients"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9387-7917","authenticated-orcid":true,"given":"Miguel","family":"Cervero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Lu\u00eds","family":"Agud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Alc\u00e1zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Jusdado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Garc\u00eda-Lacalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/hiv.12242","article-title":"Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial","volume":"16","author":"A Carr","year":"2015","journal-title":"HIV Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/QAD.0b013e32834f3507","article-title":"Body composition changes after switching from protease inhibitors to raltegravir","volume":"26","author":"A Curran","year":"2012","journal-title":"AIDS"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.abb.2010.07.029","article-title":"HIV and bone disease","volume":"503","author":"B Stone","year":"2010","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"TT Brown","year":"2006","journal-title":"AIDS"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1097\/QAD.0b013e328361d241","article-title":"Incident fractures in HIV-infected individuals","volume":"27","author":"S Shiau","year":"2013","journal-title":"AIDS"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1097\/QAD.0000000000000353","article-title":"Relative contribution of HIV infection, demographics and body mass index to body mass density","volume":"28","author":"AG Cotter","year":"2014","journal-title":"AIDS"},{"key":"ref7","first-page":"170","article-title":"Multicenter cohort of patients with HIV infection in the Madrid south-eastern metropolitan crown (COMESEM): basis, organization and initial results]","volume":"203","author":"V Castilla","year":"2003","journal-title":"Revista Cl\u00ednica Espa\u00f1ola"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAD.0b013e3282f423dd","article-title":"Reduced bone mineral density in HIV-infected patients: prevalence and associated factors","volume":"22","author":"Cazanave Ch","year":"2008","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1097\/QAD.0b013e328340a28d","article-title":"High prevalence of an progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study","volume":"24","author":"A Bonjoch","year":"2010","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/INF.0000000000001506","article-title":"Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents. Risk Factors and the Role of T-cell Activation and Senescence","volume":"36","author":"B Jim\u00e9nez","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/cen.12248","article-title":"The relationship between serum 25-hydroxy vitamin D, parathormone and bone mineral density in Indian population","volume":"80","author":"M Garg","year":"2014","journal-title":"Clinical Endocrinology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00126334-200307010-00001","article-title":"HIV infection\u2014a risk factor for osteoporosis","volume":"33","author":"J Thomas","year":"2003","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"D Marshall","year":"1996","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/QAD.0b013e32834ed8a7","article-title":"Incidence of low and high-energy fractures in persons with and without HIV infection","volume":"26","author":"A-BE Hansen","year":"2012","journal-title":"AIDS"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/infdis\/jiu499","article-title":"Low bone mineral density in patients with well-suppressed HIV infection: association with body weight, smoking, and prior advanced HIV disease","volume":"211","author":"K Kooij","year":"2015","journal-title":"JID"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/cid\/cis455","article-title":"Low Bone Mass in Behaviorally HIV-Infected Young Men on Antiretroviral Therapy: Adolescent Trials Network Study 021B","volume":"55","author":"K Mulligan","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref17","first-page":"53","article-title":"Sociedad Espa\u00f1ola de Investigaci\u00f3n \u00d3sea y del Metabolismo Mineral (SEIOMM) y Sociedades afines","volume":"3","author":"MJ G\u00f3mez de Tejada Romero","year":"2011","journal-title":"Documento de posici\u00f3n sobre las necesidades y niveles \u00f3ptimos de vitamina D. Rev Osteoporos Metab Miner"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1089\/aid.2011.0244","article-title":"Prevalence of vitamin D deficiency and Its related risk factor in a spanish cohort of adult HIV-infected patients: Effects of antiretroviral therapy","volume":"28","author":"M Cervero","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00198-013-2506-3","article-title":"Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients","volume":"25","author":"JL Casado","year":"2014","journal-title":"Osteoporos Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00002030-200104130-00022","article-title":"Osteopenia in HIV-infected patients: is it the disease or is it the treatment?","volume":"15","author":"H Knobel","year":"2001","journal-title":"AIDS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-200109070-00019","article-title":"Reduced bone mineral density in HIV-positive individuals","volume":"15","author":"AL Moore","year":"2001","journal-title":"AIDS"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy","volume":"14","author":"P Tebas","year":"2000","journal-title":"AIDS"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"JE Gallant","year":"2004","journal-title":"JAMA"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/656417","article-title":"Comparison of changes in bone density and turnover with abacavirlamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study","volume":"51","author":"H-J Stellbrink","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/infdis\/jir188","article-title":"Bone mineral density and fractures in antiretroviral-na\u00efve persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS Clinical Trials Group A5224 s, a substudy of ACTG A5202","volume":"203","author":"GA McComsey","year":"2011","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/644769","article-title":"Simplification with tenofovir-emtricitabine causes less, serious non-AIDS events than with abacavir-lamivudine: a randomized, 96-week trial","volume":"49","author":"A Martin","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/QAI.0b013e3181aa12d5","article-title":"A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir\/lamivudine or tenofovir\/emtricitabine in HIV-1-infected patients with virological suppression","volume":"51","author":"E Mart\u00ednez","year":"2009","journal-title":"BICOMBO Study Team. J Acquir Immune Defic Syndr"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/135965350701200211","article-title":"Molecular assessment of the potential for renal drug interactions between tenofovir and HIV protease inhibitors","volume":"12","author":"T Cihlar","year":"2007","journal-title":"Antivir Ther"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/QAD.0b013e328328f789","article-title":"Greater decrease in bone mineraldensity with protease inhibitor regimens compared with non nucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients","volume":"23","author":"C Duvivier","year":"2009","journal-title":"AIDS"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1468-1293.2010.00864.x","article-title":"Bone mineral density changes in protease inhibitor-sparings. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial","volume":"12","author":"AB Hansen","year":"2011","journal-title":"HIV Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/infdis\/jiw204","article-title":"Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals","volume":"214","author":"PM Grant","year":"2016","journal-title":"J Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T11:55:50Z","timestamp":1661082950000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196201"}},"subtitle":[],"editor":[{"given":"Alan","family":"Winston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,30]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196201","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,30]]}}}